Response from Piotr Mieszcazanski regarding Ceren Gunt's letter-RE: "Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study". Mieszczanski P. Transplant Proc 2021 Nov 22. pii: S0041-1345(21)00743.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mieszczanski P. Response from Piotr Mieszcazanski regarding Ceren Gunt's letter-RE: "Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study". Transplant Proc 2021 Nov 22. pii: S0041-1345(21)00743.
PMID: 34823898